Table 4 Continued acceptance of treatment in view of information on potential side effects
Continue to accept treatment despite side effects* | ||||
|---|---|---|---|---|
Accepting, n (%) | ORcrude | ORadj** (95%-CI) | Test for trend | |
Total | 156 (42.7) | - | - | - |
Gender | p = 0.889 | p = 0.832 | ||
Male | 84 (43.1) | (ref) | (ref) | - |
Female | 72 (42.4) | 0.97 | 0.95 (0.62, 1.47) | |
Age groups | p = 0.205 | p = 0.257 | ||
40-44 | 18 (34.6) | (ref) | (ref) | pcrude = 0.838 |
45-49 | 47 (51.7) | 2.02 | 1.96 (0.96, 4.03) | padj = 0.960 |
50-54 | 37 (41.1) | 1.32 | 1.23 (0.60, 2.54) | |
55-60 | 54 (40.9) | 1.31 | 1.38 (0.70, 2.74) | |
Health status | p = 0.804 | p = 0.682 | ||
Good/very good | 95 (44.0) | (ref) | (ref) | pcrude = 0.577 |
Fair | 48 (40.3) | 0.86 | 0.97 (0.43, 2.22) | padj = 0.458 |
Poor/very poor | 12 (41.4) | 0.90 | 1.24 (0.59, 2.58) | |
Experience with heart disease | p = 0.656 | p = 0.609 | - | |
Yes, have or have had myself | 14 (40.0) | (ref) | (ref) | |
Yes, family member has had | 34 (39.1) | 0.96 | 0.81 (0.50, 1.31) | |
No | 103 (44.4) | 1.20 | 0.86 (0.38, 1.97) | |
Price | p = 0.402 | p = 0.401 | ||
DKK 100 | 69 (45.7) | (ref) | (ref) | pcrude = 0.725 |
DKK 400 | 43 (37.7) | 0.72 | 0.71 (0.43, 1.18) | padj = 0.705 |
DKK 700 | 44 (44.4) | 0.95 | 0.94 (0.56, 1.59) | |